Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"G protein subunit alpha L" is not a standard, widely recognized name for any human G protein alpha subunit. Heterotrimeric G proteins consist of alpha, beta, and gamma subunits, with the alpha subunit playing a central role in GDP/GTP binding and hydrolysis and determining G protein class and signaling specificity. Major alpha subunit subfamilies include Gαs, Gαi/o, Gαq/11, and Gα12/13, each encoded by distinct genes. The subclass "L" does not match these canonical classifications, and no major databases or reviews identify a "G protein subunit alpha L" as a separate entity. This suggests the term is either a misnomer, transcription/translation error, or an extremely rare/obsolete alias for another alpha subunit, potentially GNAI3 (Gαi3), although this is not definitive. Therefore, "G protein subunit alpha L" should be considered ambiguous or incorrect for structured biomedical curation.
For drugs/toxins that affect G proteins: typically modulation of GDP/GTP binding, inhibition or activation of downstream effectors, or disruption of Gα subunit interactions
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein subunit alpha L (GαL).